The KCB COVID-19 Antigen Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present in the human nasopharynx.

It is reserved for professional in vitro diagnostic use.

• Detects antigens of SARS-CoV-2, responsible for COVID-19
• Nasopharyngeal swab
• No laboratory analysis
• Indicates whether the patient is infected or not at the time of the test
• Result in 15 minutes
• CE marked & Approved by the French Ministry of Health.
• Sensitivity >96%, Specificity >99% vs RT-PCR

Box of 20 tests including everything necessary for the realization

20 test cassettes
2 vials of buffer
20 sterile nasopharyngeal swabs
20 extraction tubes
1 tube holder
1 user manual

Ask us for a quote on +33 (0) 4 70 08 08 80

Mail: info@kappa-city.fr

Procedure

Founded in 2005, Kappa City Biotech SAS is specialized in the manufacturing of In Vitro Diagnostic (IVD) medical devices, and more particularly of lateral flow immunoassays, or in other words, rapid tests based on the principle of an antibody/antigen reaction.

We pursue a triple objective:

• Provide our professional clients with cutting edge diagnostic tools, easy to use, of premium quality, and of course made in France
• Democratize the use of rapid diagnostic tests among the general population, and thus, meet the pressing need of private individuals for this type of helpful tool.
• Contribute as much as possible to France’s international reputation for excellence in biotechnologies

Our Research and Development department is at your disposal to study your project. Whatever you marker of interest can be, there must be a solution to screen and detect it with a lateral flow test.

And if you haven’t identified yet the specific marker of the the product or molecule you wish to screen for, we will help you find it!